CD200 positive human mesenchymal stem cells suppress TNF-alpha secretion from CD200 receptor positive macrophage-like cells

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Pietilä, Mika ^a,b   Lehtonen, Siri ^a,b   Tuovinen, Elina ^c   Lähteenmäki, Kaarina ^c   Laitinen, Saara ^c   Leskelä, Hannu Ville ^a,b   Nätynki, Antti ^a,b   Pesälä, Juha ^a,b   Nordström, Katrina ^d   Lehenkari, Petri ^a,b  

^a UNIVERSITY OF OULU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c FINNISH RED CROSS BLOOD SERVICE   (Finland)

^d AALTO UNIVERSITY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CD200 ANTIGEN; CD200 RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; ANTIBODY; ANTIGENS, CD200; CD200R1 PROTEIN, HUMAN; CELL SURFACE RECEPTOR; LEUKOCYTE ANTIGEN; MEMBRANE ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL LINE; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; MACROPHAGE; MACROPHAGE ACTIVATION; MESENCHYMAL STEM CELL; RECEPTOR BINDING; STEM CELL; UMBILICAL CORD BLOOD DERIVED MESENCHYMAL STEM CELL; BONE MARROW CELL; CYTOLOGY; DRUG EFFECT; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; SECRETION;

ANTIBODIES; ANTIGENS, CD; ANTIGENS, SURFACE; BONE MARROW CELLS; CELL LINE; COCULTURE TECHNIQUES; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSION; INTERFERON-GAMMA; INTERLEUKIN-10; MACROPHAGE ACTIVATION; MACROPHAGES; MESENCHYMAL STEM CELLS; RECEPTORS, CELL SURFACE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84857434882     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031671     Document Type: Article

References (59)

1. Medzhitov R, Janeway CA Jr, (1997) Innate immunity: The virtues of a nonclonal system of recognition. Cell 91 (3): 295-298.
2. Medzhitov R, Janeway CA Jr, (1997) Innate immunity: Impact on the adaptive immune response. Curr Opin Immunol 9 (1): 4-9.
3. Mosser DM, Edwards JP, (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8 (12): 958-969.
4. Bystrom J, Evans I, Newson J, Stables M, Toor I, et al. (2008) Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP. Blood 112 (10): 4117-4127.
5. Young HA, Hardy KJ, (1995) Role of interferon-gamma in immune cell regulation. J Leukoc Biol 58 (4): 373-381.
6. Fernandes JL, Mamoni RL, Orford JL, Garcia C, Selwyn AP, et al. (2004) Increased Th1 activity in patients with coronary artery disease. Cytokine 26 (3): 131-137.
7. Strober W, Zhang F, Kitani A, Fuss I, Fichtner-Feigl S, (2010) Proinflammatory cytokines underlying the inflammation of crohn's disease. Curr Opin Gastroenterol 26 (4): 310-317.
8. Shi D, Das J, Das G, (2006) Inflammatory bowel disease requires the interplay between innate and adaptive immune signals. Cell Res 16 (1): 70-74.
9. Harvey EJ, Ramji DP, (2005) Interferon-gamma and atherosclerosis: Pro- or anti-atherogenic? Cardiovasc Res 67 (1): 11-20.
10. Brown J, Wallet MA, Krastins B, Sarracino D, Goodenow MM, (2010) Proteome bioprofiles distinguish between M1 priming and activation states in human macrophages. J Leukoc Biol 87 (4): 655-662.
11. Aggarwal S, Pittenger MF, (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105 (4): 1815-1822.
12. Jiang XX, Zhang Y, Liu B, Zhang SX, Wu Y, et al. (2005) Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105 (10): 4120-4126.
13. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringden O, (2003) Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 57 (1): 11-20.
14. Puissant B, Barreau C, Bourin P, Clavel C, Corre J, et al. (2005) Immunomodulatory effect of human adipose tissue-derived adult stem cells: Comparison with bone marrow mesenchymal stem cells. Br J Haematol 129 (1): 118-129.
15. Wang M, Yang Y, Yang D, Luo F, Liang W, et al. (2009) The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro. Immunology 126 (2): 220-232.
16. Duijvestein M, Vos AC, Roelofs H, Wildenberg ME, Wendrich BB, et al. (2010) Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal crohn's disease: Results of a phase I study. Gut 59 (12): 1662-1669.
17. Gonzalez MA, Gonzalez-Rey E, Rico L, Buscher D, Delgado M, (2009) Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology 136 (3): 978-989.
18. Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, et al. (2008) Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study. Lancet 371 (9624): 1579-1586.
19. Longoni B, Szilagyi E, Quaranta P, Paoli GT, Tripodi S, et al. (2010) Mesenchymal stem cells prevent acute rejection and prolong graft function in pancreatic islet transplantation. Diabetes Technol Ther 12 (6): 435-446.
20. Opitz CA, Litzenburger UM, Lutz C, Lanz TV, Tritschler I, et al. (2009) Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via interferon-beta and protein kinase R. Stem Cells 27 (4): 909-919.
21. Ryan JM, Barry F, Murphy JM, Mahon BP, (2007) Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin Exp Immunol 149 (2): 353-363.
22. Lepelletier Y, Lecourt S, Renand A, Arnulf B, Vanneaux V, et al. (2010) Galectin-1 and semaphorin-3A are two soluble factors conferring T-cell immunosuppression to bone marrow mesenchymal stem cell. Stem Cells Dev 19 (7): 1075-1079.
23. Ren G, Zhao X, Zhang L, Zhang J, L'Huillier A, et al. (2010) Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression. J Immunol 184 (5): 2321-2328.
24. Campioni D, Rizzo R, Stignani M, Melchiorri L, Ferrari L, et al. (2009) A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs. Cytometry B Clin Cytom 76 (3): 225-230.
25. Barclay AN, Clark MJ, McCaughan GW, (1986) Neuronal/lymphoid membrane glycoprotein MRC OX-2 is a member of the immunoglobulin superfamily with a light-chain-like structure. Biochem Soc Symp 51: 149-157.
26. McCaughan GW, Clark MJ, Barclay AN, (1987) Characterization of the human homolog of the rat MRC OX-2 membrane glycoprotein. Immunogenetics 25 (5): 329-335.
27. Delorme B, Ringe J, Gallay N, Le Vern Y, Kerboeuf D, et al. (2008) Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells. Blood 111 (5): 2631-2635.
28. Wright GJ, Puklavec MJ, Willis AC, Hoek RM, Sedgwick JD, et al. (2000) Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function. Immunity 13 (2): 233-242.
29. Hoek RM, Ruuls SR, Murphy CA, Wright GJ, Goddard R, et al. (2000) Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 290 (5497): 1768-1771.
30. Snelgrove RJ, Goulding J, Didierlaurent AM, Lyonga D, Vekaria S, et al. (2008) A critical function for CD200 in lung immune homeostasis and the severity of influenza infection. Nat Immunol 9 (9): 1074-1083.
31. Lyons A, Downer EJ, Crotty S, Nolan YM, Mills KH, et al. (2007) CD200 ligand receptor interaction modulates microglial activation in vivo and in vitro: A role for IL-4. J Neurosci 27 (31): 8309-8313.
32. Taylor S, Calder CJ, Albon J, Erichsen JT, Boulton ME, et al. (2011) Involvement of the CD200 receptor complex in microglia activation in experimental glaucoma. Exp Eye Res.
33. Broderick C, Hoek RM, Forrester JV, Liversidge J, Sedgwick JD, et al. (2002) Constitutive retinal CD200 expression regulates resident microglia and activation state of inflammatory cells during experimental autoimmune uveoretinitis. Am J Pathol 161 (5): 1669-1677.
34. Gorczynski RM, Chen Z, Lee L, Yu K, Hu J, (2002) Anti-CD200R ameliorates collagen-induced arthritis in mice. Clin Immunol 104 (3): 256-264.
35. Gorczynski RM, Chen Z, Yu K, Hu J, (2001) CD200 immunoadhesin suppresses collagen-induced arthritis in mice. Clin Immunol 101 (3): 328-334.
36. Matsue H, (2005) CD 200-mediated regulation of skin immunity. J Invest Dermatol 125 (6): x-xi.
37. Zhang QZ, Su WR, Shi SH, Wilder-Smith P, Xiang AP, et al. (2010) Human gingiva-derived mesenchymal stem cells elicit polarization of m2 macrophages and enhance cutaneous wound healing. Stem Cells 28 (10): 1856-1868.
38. Kim J, Hematti P, (2009) Mesenchymal stem cell-educated macrophages: A novel type of alternatively activated macrophages. Exp Hematol 37 (12): 1445-1453.
39. Leskela HV, Risteli J, Niskanen S, Koivunen J, Ivaska KK, et al. (2003) Osteoblast recruitment from stem cells does not decrease by age at late adulthood. Biochem Biophys Res Commun 311 (4): 1008-1013.
40. Laitinen A, Nystedt J, Laitinen S, (2011) The isolation and culture of human cord blood-derived mesenchymal stem cells under low oxygen conditions. Methods Mol Biol 698: 63-73.
41. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. the international society for cellular therapy position statement. Cytotherapy 8 (4): 315-317.
42. Maggini J, Mirkin G, Bognanni I, Holmberg J, Piazzon IM, et al. (2010) Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS One 5 (2): e9252.
43. Asseffa A, Dickson LA, Mohla S, Bremner TA, (1993) Phorbol myristate acetate-differentiated THP-1 cells display increased levels of MHC class I and class II mRNA and interferon-gamma-inducible tumoricidal activity. Oncol Res 5 (1): 11-18.
44. Kang SS, Woo SS, Im J, Yang JS, Yun CH, et al. (2007) Human placenta promotes IL-8 expression through activation of JNK/SAPK and transcription factors NF-kappaB and AP-1 in PMA-differentiated THP-1 cells. Int Immunopharmacol 7 (11): 1488-1495.
45. Kosaka C, Masuda J, Shimokado K, Zen K, Yokota T, et al. (1992) Interferon-gamma suppresses PDGF production from THP-1 cells and blood monocyte-derived macrophages. Atherosclerosis 97 (1): 75-87.
46. Schwende H, Fitzke E, Ambs P, Dieter P, (1996) Differences in the state of differentiation of THP-1 cells induced by phorbol ester and 1,25-dihydroxyvitamin D3. J Leukoc Biol 59 (4): 555-561.
47. Chow A, Lucas D, Hidalgo A, Mendez-Ferrer S, Hashimoto D, et al. (2011) Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. J Exp Med 208 (2): 261-271.
48. Ehninger A, Trumpp A, (2011) The bone marrow stem cell niche grows up: Mesenchymal stem cells and macrophages move in. J Exp Med 208 (3): 421-428.
49. Cui W, Cuartas E, Ke J, Zhang Q, Einarsson HB, et al. (2007) CD200 and its receptor, CD200R, modulate bone mass via the differentiation of osteoclasts. Proc Natl Acad Sci U S A 104 (36): 14436-14441.
50. Miettinen JA, Pietila M, Salonen RJ, Ohlmeier S, Ylitalo K, et al. (2011) Tumor necrosis factor alpha promotes the expression of immunosuppressive proteins and enhances the cell growth in a human bone marrow-derived stem cell culture. Exp Cell Res 317 (6): 791-801.
51. Croitoru-Lamoury J, Lamoury FM, Caristo M, Suzuki K, Walker D, et al. (2011) Interferon-gamma regulates the proliferation and differentiation of mesenchymal stem cells via activation of indoleamine 2,3 dioxygenase (IDO). PLoS One 6 (2): e14698.
52. Jenmalm MC, Cherwinski H, Bowman EP, Phillips JH, Sedgwick JD, (2006) Regulation of myeloid cell function through the CD200 receptor. J Immunol 176 (1): 191-199.
53. Langlais CL, Jones JM, Estep RD, Wong SW, (2006) Rhesus rhadinovirus R15 encodes a functional homologue of human CD200. J Virol 80 (6): 3098-3103.
54. Salata C, Curtarello M, Calistri A, Sartori E, Sette P, et al. (2009) vOX2 glycoprotein of human herpesvirus 8 modulates human primary macrophages activity. J Cell Physiol 219 (3): 698-706.
55. Daigneault M, Preston JA, Marriott HM, Whyte MK, Dockrell DH, (2010) The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS One 5 (1): e8668.
56. Simelyte E, Alzabin S, Boudakov I, Williams R, (2010) CD200R1 regulates the severity of arthritis but has minimal impact on the adaptive immune response. Clin Exp Immunol 162 (1): 163-168.
57. Simelyte E, Criado G, Essex D, Uger RA, Feldmann M, et al. (2008) CD200-fc, a novel antiarthritic biologic agent that targets proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis. Arthritis Rheum 58 (4): 1038-1043.
58. Kawasaki BT, Farrar WL, (2008) Cancer stem cells, CD200 and immunoevasion. Trends Immunol 29 (10): 464-468.
59. Kawasaki BT, Mistree T, Hurt EM, Kalathur M, Farrar WL, (2007) Co-expression of the toleragenic glycoprotein, CD200, with markers for cancer stem cells. Biochem Biophys Res Commun 364 (4): 778-782.